ZARVY

Montair 5 is a chewable tablet containing Montelukast 5mg, formulated with a pleasant strawberry flavor to support pediatric and adolescent patients in managing respiratory and allergic conditions. It belongs to a class of medications known as leukotriene receptor antagonists (LTRAs) and works by blocking leukotrienes—chemical messengers responsible for airway inflammation and allergy symptoms. By suppressing this pathway, Montair 5 helps relieve symptoms in asthma, allergic rhinitis, and exercise-induced bronchospasm. This medication is particularly effective in the Respiratory Diseases category, especially under subcategories like Asthma / COPD and Allergic Rhinitis. It helps reduce wheezing, shortness of breath, nasal congestion, sneezing, and itchy, watery eyes. Its chewable format and pediatric-friendly flavor make it especially suitable for children aged 6 to 15 years, where it provides daily preventive care and symptom control in chronic asthma or allergic conditions triggered by seasonal changes, dust, or environmental irritants.

Montair 10 is an oral chewable tablet containing Montelukast 10mg, a leukotriene receptor antagonist widely used in the management of asthma, allergic rhinitis, and related respiratory diseases. This generic formulation from Cipla Ltd. is designed to ease breathing, reduce airway inflammation, and prevent asthma-related symptoms triggered by allergens, exercise, or environmental factors. As part of the Respiratory Diseases category, Montair 10 is especially effective in managing Asthma/COPD by inhibiting leukotriene-mediated bronchoconstriction. In addition, it is widely prescribed to alleviate symptoms of Allergic Rhinitis, including nasal congestion, sneezing, runny nose, and itchy eyes. Its once-daily dosing and chewable formulation make it a convenient option for both adults and pediatric patients. Montelukast works by blocking leukotrienes—chemical substances released in the body in response to allergens like pollen or dust. These leukotrienes cause swelling in airways and excess mucus production. By reducing their effects, Montair 10 helps relieve chronic respiratory symptoms and reduces the frequency of asthma attacks.

Allegra-M is a dual-action anti-allergic medication containing Fexofenadine 120mg and Montelukast 10mg, developed to provide effective relief from respiratory and seasonal allergy symptoms. This generic formulation by Sanofi targets both histamine and leukotriene pathways, offering comprehensive control over sneezing, runny nose, nasal congestion, and watery eyes. The synergistic combination of Fexofenadine, a non-sedating H1-antihistamine, and Montelukast, a leukotriene receptor antagonist, helps reduce inflammation, swelling, and mucus secretion triggered by allergens. This makes Allegra-M particularly effective for individuals with persistent or moderate-to-severe allergic rhinitis, especially when monotherapy is insufficient

Montair FX is a dual-action anti-allergic medication that combines Fexofenadine 120mg and Montelukast 10mg, formulated to relieve both nasal and ocular allergy symptoms in a single daily dose. Manufactured by Cipla Ltd, this generic combination provides comprehensive relief for individuals suffering from allergic rhinitis, hay fever, and upper respiratory hypersensitivity symptoms. Fexofenadine is a second-generation antihistamine that blocks the H1 receptor to prevent histamine-related symptoms such as sneezing, runny nose, and itchy eyes, without causing drowsiness. Montelukast complements this effect by acting as a leukotriene receptor antagonist, reducing inflammation, mucus secretion, and bronchial constriction triggered by allergens. Montair FX is particularly effective for patients whose symptoms are not fully controlled with antihistamines alone. It also benefits those with comorbid asthma or allergic conjunctivitis. The synergistic action ensures 24-hour protection against seasonal and perennial allergy triggers, making it a convenient, once-daily solution